Skip to main content

Advertisement

SpringerLink
Log in

Immunosuppression in murine renal cell carcinoma

I. Characterization of extent, severity and sources

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Four cell-mediated immunological responses related to tumor elimination have been examined in mice injected with a transplantable renal cell carcinoma (Renca). Lymphokine-activated killer (LAK) cells generatedin vitro from spleen cells of normal mice were capable of attacking Renca, EL-4, P815 and YAC-1 targets, but those from mice bearing Renca for 3 weeks could not. Natural killer activity, stimulatedin vivo by administering poly(I) poly(C), was less than 50% of normal in Rencabearing hosts. In addition, development of cytotoxic T lymphocytes to allogeneic targets was markedly inhibited in mice possessing the renal tumor. Finally, the delayed hypersensitivity response to a dermally applied hapten was approximately 70% less than normal in tumor-bearing mice, no matter whether the tumor existed subcutaneously or intrarenally. A kinetic study of the development of nonresponsiveness using the LAK assay showed onset of poor response at 1 week, which became maximal within 3 weeks following receipt of tumor subcutaneously. The immunological depression was seen to be attributable in part to suppressor cells present among spleen cells but not bone marrow cells of tumor-bearing hosts. The suppressor cells preventedin vitro LAK generation by normal spleen cells and, when adoptively transferred to normal mice, they inhibited natural killer stimulation and delayed hypersensitivity generation. Another source of immunological downregulation was provided by Renca cells themselves. Incorporation of Renca cells that had been X-irradiated with 30000 rad into cultures of normal and Renca-derived splenic cells suppressed replication of both almost completely. Furthermore, the presence of X-irradiated Renca cells in cultures of normal spleen cells prevented development of LAK cells. Thus, the suppression seen in Renca-bearing mice derives from multiple sources and whether each is in any way related to the other has been discussed. Identification of the phenotypes of cells responsible for the lymphoid cell-mediated suppression and examination of its elimination are communicated in the companion paper.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Asherson GL, Zembala M (1982) The role of T acceptor cell in suppressor systems: antigen specific T suppressor factor acts via a T acceptor cell; this releases a non-specific inhibitor of the transfer of contact sensitivity when exposed to antigen in the context of I-J. Ann NY Acad Sci 392: 71

    Google Scholar 

  2. Bassil B, Dosoretz DE, Prout GR, Jr (1985) Validation of the tumor, nodes and metastasis classification of renal cell carcinoma. J Urol 134: 450

    Google Scholar 

  3. Bear HD (1986) Tumor-specific T-cells which inhibit thein vitro generation of cytolytic T-cells from immune and early tumor bearing host spleens. Cancer Res 46: 1805

    Google Scholar 

  4. Bear HD, Susskind BM, Close KA, Barrett SK (1988) Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for theirin vitro generation from tumor-bearing host and immune spleens. Cancer Res 48: 1422

    Google Scholar 

  5. Berendt MJ, North RJ (1980) T-cell-mediated suppression of antitumor immunity. J Exp Med 151: 69

    Google Scholar 

  6. Bluestone JA, Lopez C (1979) Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells. J Natl Cancer Inst 63: 1221

    Google Scholar 

  7. Bukowski RM (1981) Suppressor cells in oncology. In: Suppressor cells and their factors. CRC Press, Boca Raton, Fla, p 103

    Google Scholar 

  8. Chow KN, Battisto JR (1988) Down-regulation of cytotoxic T-lymphocytes development by a minor stimulating locus-induced suppressor cascade that involved Lyt1+T-cells, Ia−macrophages, and their factors. J Immunol 140: 1

    Google Scholar 

  9. DiGiacoma A, North RJ (1986) T cell suppressors of antitumor immunity. J Exp Med 164: 1179

    Google Scholar 

  10. Dye ES, North RJ (1981) T-cell mediated immunosuppression: an obstacle to adoptive immunotherapy of the p815 mastocytoma and its metastasis. J Exp Med 154: 1033

    Google Scholar 

  11. Ebihara T, Koyama S, Fukao K, Osuga T (1989) Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma. Cancer Immunol Immunother 28: 218

    Google Scholar 

  12. Elgert KD, Farrar WL (1978) Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T-lymphocytes and macrophages. J Immunol 120: 1345

    Google Scholar 

  13. Eura M, Maehara T, Ikawa T, Ishikawa T (1988) Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients. Cancer Immunol Immunother 27: 147

    Google Scholar 

  14. Fujii T, Igaraski T, Kishimoto S (1987) Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. J Natl Cancer Inst 78: 509

    Google Scholar 

  15. Garner RE, Elgert KD (1986) Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes. J Leukocyte Biol 40: 709

    Google Scholar 

  16. Garner RE, Malick AD, Yurochko AD, Elgert KD (1987) Shifts in macrophage surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ macrophage with immunosuppressive activity. Cell Immunol 108: 255

    Google Scholar 

  17. Gautam SC, Battisto JR (1983) Suppression of contact sensitivity and cell-mediated lympholysis by oral administration of hapten is caused by different mechanisms. Cell Immunol 78: 295

    Google Scholar 

  18. Gautam SC, Battisto JR (1985) Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J Immunol 135: 2975

    Google Scholar 

  19. Gautam SC, Battisto JR (1989) Feeding trinitrochlorobenzene inhibits development of hapten T-cell function. Regional Immunol 2: 33

    Google Scholar 

  20. Gorelik E, Wiltrout R, Okumura K, Habu S, Herberman RB (1982) Excelleration of the metastatic growth in anti-asialo-GM1-treated mice In: NK cells and other natural effector cells, Academic Press, New York, p 1331

    Google Scholar 

  21. Gregorian SK, Battisto JR (1990) Immunosuppression in renal cell carcinoma: II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression. Cancer Immunol Immunother 31: 335–341

    Google Scholar 

  22. Grimm EA (1986) Human lymphokine activated killer cells as a potential immunotherapeutic modality. Biochim Biophys Acta 865: 867

    Google Scholar 

  23. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823

    Google Scholar 

  24. Guillou PJ, Sedman PC, Ramsden CW (1989) Inhibition of lymphokine-activated killer cell generation by cultured tumor cell linesin vitro. Cancer Immunol Immunother 28: 4

    Google Scholar 

  25. Herberman RB, Nunn ME, Holden HT, Stale S, Djeu JY (1977) Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogenic target cells. Int J Cancer 19: 555

    Google Scholar 

  26. Hrushesky WJ, Murphy GP (1973) Investigation of a new renal tumor model. J Surg Res 15: 327

    Google Scholar 

  27. Huben RP, Connely R, Goldrosen MH, Murphy GP, Pontes EJ (1983) Immunotherapy of a murine renal cancer. J Urol 129: 1075

    Google Scholar 

  28. Kamo I, Friedman H (1977) Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res 25: 271

    Google Scholar 

  29. Lala PK, Santer V, Libenson H, Parhar RS (1985) Changes in the host natural killer cell population in mice during tumor development. I. Kinetics andin vitro significance. Cell Immunol 93: 250

    Google Scholar 

  30. Loutit JF, Townsand KMS, Knowles JR (1980) Tumor surveillance in beige mice. Nature 285: 66

    Google Scholar 

  31. Maccubbin DL, Mace KF, Ehrke MJ, Mihich E (1989) Modification of host antitumor defense mechanisms in mice by progressively growing tumor. Cancer Res 49: 4216

    Google Scholar 

  32. Mazumder A, Rosenberg SA (1984) Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated by interleukin-2. J Exp Med 159: 495

    Google Scholar 

  33. Mills CD, North RJ, Dye ES (1981) Mechanism of anti-tumor action ofCorynebacterium parvum. Potentiated cytolytic T cell response and its tumor-induced suppression. J Exp Med 54: 621

    Google Scholar 

  34. Murphy GP, Hrushesky WJ (1973) A murine renal cell carcinoma. J Natl Cancer Inst 50: 1013

    Google Scholar 

  35. Nepom GT, Hellstrom I, Hellstrom KE (1983) Suppressor mechanisms in tumor immunity. Experientia 39: 235

    Google Scholar 

  36. North RJ, Bursuker I (1984) Generation and decay of immune response to a progressive fibrosarcoma: I. Lyt1+2− suppressor T cells down regulate the generation of Lyt1−2+ effector T cells. J Exp Med 159: 1295

    Google Scholar 

  37. North RJ, Dye ES (1985) Lyt1+2− suppressor T cells down regulate the generation of Lyt1−2+ effector T cells during progressive growth of mastocytoma. Immunology 54: 47

    Google Scholar 

  38. North RJ, Dye ES, Mills CT (1982) T-cell mediated negative regulation of concomitant anti-tumor immunity as an obstacle to adoptive immunotherapy of established tumors. In: The potential role of T-cells in cancer therapy. Raven Press, NY, p 65

    Google Scholar 

  39. Parhar RS, Lala PK (1985) Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity. Cell Immunol 93: 265

    Google Scholar 

  40. Remacle-Bonnet MM, Pommier GJ, Kaplauski S, Rance AJ, Depiech RC (1976) Inhibition of normal allogeneic lymphocyte mitogenesis by a soluble inhibitor extracted from human colonic carcinoma. J Immunol 117: 1145

    Google Scholar 

  41. Rosenberg SA (1985) Lymphokine activated killer cells: a new approach to immunotherapy of cancer. J Natl Cancer Inst 75: 595

    Google Scholar 

  42. Roth JA, Grimm EA, Gupta RK, Ames RS (1982) Immuno regulatory factors derived from human tumors I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferation and cytotoxic responsesin vitro. J Immunol 128: 1922

    Google Scholar 

  43. Salup RR, Wiltrout RH (1985) Adjuvant immunotherapy of established murine renal cancer by interleukin-2 stimulated cytotoxic lymphocytes. Cancer Res 46: 335

    Google Scholar 

  44. Salup RR, Herberman RB, Wiltrout RH (1985) Role of natural killer activity in development of spontaneous metastases in murine renal cancer. J Urol 134: 1236

    Google Scholar 

  45. Salup RR, Back TC, Wiltrout RH (1987) Successful treatment of advanced murine renal cell cancer by bicompartmental adoptive chemoimmunotherapy. J Immunol 138: 641

    Google Scholar 

  46. Taramelli D, Fossati G, Balbsari A, Marolda R, Parmiani G (1984) The inhibition of lymphocyte stimulation by autologus human metastatic melanoma cells correlated with the expression of HLA-DT antigens on the tumor cells. Int J Cancer 34: 797

    Google Scholar 

  47. Ting CC, Hargrove ME (1982) Tumor cell-triggered macrophagemediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression. J Natl Cancer Inst 69: 873

    Google Scholar 

  48. Ting CC, Rodrigues D (1980) Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance. Proc Natl Acad Sci USA 77: 4265

    Google Scholar 

  49. Ting CC, Rodrigues D (1982) Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. J Natl Cancer Inst 69: 867

    Google Scholar 

  50. Ting CC, Wunderlich JR, Hargrove ME, Winkler D (1985)In vitro andin vivo antitumor activity of lymphokine-induced cytotoxic cells. Int J Cancer 36: 117

    Google Scholar 

  51. Ting CC, Hargrove ME, Stephany D (1987) Generation of activated killer cells in tumor-bearing hosts. Int J Cancer 34: 797

    Google Scholar 

  52. Whitehead JS, Kim YS (1980) An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture. Cancer Res 40: 29

    Google Scholar 

  53. Wiltrout RH, Boyd MR, Back TC, Salup RR, Arthur JA, Hornung RL (1988) Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer. J Immunol 140: 3261

    Google Scholar 

  54. Yurochko AD, Pyle RH, Elgert KD (1989) Changes in macrophage populations: Phenotypic differences between the normal and tumorbearing host macrophages. Immunobiology 178: 416

    Google Scholar 

  55. Yurochko AD, Nagarkatti PS, Nagarkatti M, Elgert KD (1989) Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells. Cancer Immunol Immunother 30: 170

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Cleveland State University, 44115, Cleveland, Ohio, USA

    Shahik K. Gregorian

  2. Section of Immunology and Cancer, The Research Institute, Cleveland Clinic Foundation, 44195-5068, Cleveland, Ohio, USA

    Jack R. Battisto

Authors
  1. Shahik K. Gregorian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack R. Battisto
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Offered in partial fulfillment of the requirements for the Ph. D. degree at Cleveland State University by SKG.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gregorian, S.K., Battisto, J.R. Immunosuppression in murine renal cell carcinoma. Cancer Immunol Immunother 31, 325–334 (1990). https://doi.org/10.1007/BF01741403

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741403

Keywords

Search

Navigation